Mount Yale Investment Advisors, LLC Axonics, Inc. Transaction History

Mount Yale Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$48.64 - $62.51 $5,885 - $7,563	-121 Reduced 3.02%	3,880 $217,000
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $9,933 - $12,463	207 Added 5.46%	4,001 $201,000
Q1 2023 May 11, 2023	SELL	$52.6 - $67.34 $5,102 - $6,531	-97 Reduced 2.49%	3,794 $207,000
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $164,504 - $211,569	-2,762 Reduced 41.52%	3,891 $243,000
Q3 2022 Nov 07, 2022	BUY	$57.96 - $78.12 $130,873 - $176,394	2,258 Added 51.38%	6,653 $469,000
Q2 2022 Aug 02, 2022	BUY	$39.5 - $64.42 $41,712 - $68,027	1,056 Added 31.63%	4,395 $249,000
Q1 2022 May 03, 2022	BUY	$43.74 - $62.76 $146,047 - $209,555	3,339 New	3,339 $209,000
Q4 2021 Feb 02, 2022	SELL	$50.01 - $73.35 $166,133 - $243,668	-3,322 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$59.21 - $78.66 $3,256 - $4,326	55 Added 1.68%	3,322 $216,000
Q2 2021 Aug 04, 2021	BUY	$51.39 - $66.9 $167,891 - $218,562	3,267 New	3,267 $207,000

233

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.